Elutia

ELUTNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$34.745 M

$0.78 +3.28%

Close of 6 Nov 2026

As of 6 Nov 2026, Elutia (ELUT) has a market capitalization of $34.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$53.4M

#1533 by earnings

Shares outstanding

—

Latest filing cover page

P/E ratio

0.7

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#131Inmune BioINMB$36.8M
#132Pelthos TherapeuticsPTHS$36.7M
#133ElutiaELUT$34.7M
#134Aligos TherapeuticsALGS$28.6M
#135Metagenomi TherapeuticsMGX$27.7M

What if Elutia were worth as much as…

Open the what-if tool →

Gold $28.2T

$637,556.21

Per share 812,691× higher

Bitcoin $1.53T

$34,497.06

Per share 43,973× higher

Apple $5.02T

$113,250.62

Per share 144,360× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Elutia are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.